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We investigated childhood brain tumours by histological subtype in relation to prenatal X-ray among all children, less than 15 years of
age, born in Sweden between 1975 and 1984. For each case, one control was randomly selected from the Medical Birth Register, and
exposure data on prenatal X-ray were extracted blindly from antenatal medical records. Additional information on maternal
reproductive history was obtained from the Medical Birth Register. We found no overall increased risk for childhood brain tumour
after prenatal abdominal X-ray exposure (adjusted odds ratio (OR): 1.02, 95% confidence interval (CI): 0.64–1.62); primitive
neuroectodermal tumours had the highest risk estimate (OR: 1.88, 95% CI: 0.92–3.83).
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From 1975 to 2002, the incidence rate of childhood brain tumours
(CBTs) in the United States increased from 2.3 to 3.5 cases per
100000 children (NCI, 2005). A step increase was noted in
1984–1985, for which suggested reasons were better diagnostic
procedures with MRI and changes in the histological classification
(Smith et al, 1998). However, in a Swedish study between 1973 and
1992, the increase was around 2.6% annually, with no time
clustering (Hjalmars et al, 1999). It is still unclear, therefore,
whether the observed trend is a true increase or an effect of better
diagnostic procedures.
Few risk factors are considered as established: rare genetic
disorders and high-dose ionising radiation for cancer therapy and
tinea capitis (Ron et al, 1988; Bunin, 2000; Baldwin and Preston-
Martin, 2004). Radiological examinations during pregnancy have
in some studies been associated with a slightly increased risk of
CBT in offspring (Bithell and Stewart, 1975; Rodvall et al, 1990;
Shu et al, 1994). However, meta-analyses have found no clear
associations (Gurney et al., 1999; Bunin, 2000; Linet et al, 2003).
During recent years, more focus has been on risk factors for the
subtypes of CBT, since their cellular origins as well as geographic
distribution differ. The few previously existing studies on prenatal
X-ray and subtypes of CBT are based on retrospectively collected
information and exposure frequency was low (Bunin et al, 1994;
Schuz et al, 2001).
The aim with this study was to assess any association between
prenatal exposure to diagnostic X-ray and primary CBT in a
population-based case–control study, including subanalyses
according to histological subtype. To avoid selection and recall
bias, we performed a nation-wide study, where information on
X-ray had been prospectively recorded in antenatal records.
MATERIALS AND METHODS
All children born between 1975 and 1984 in Sweden were eligible
for this study. We used the nation-wide Swedish Cancer Register
to identify children with brain tumours and for histological
classification. The Cancer Register uses the 7th revision of the
International Classification of Diseases (ICD-7) to facilitate
comparison over time. Cases were children less than 15 years of
age, diagnosed with brain tumour (ICD-7, code 193). The
histological subtypes are defined through the three-digit patho-
histological diagnosis code assigned by a pathologist. Controls
were randomly selected children from the Medical Birth Register
and frequency matched to cases by gender and year of birth.
Controls had to be alive and residents in Sweden until the age of 15
years, which was ensured by using information from the Cause of
Death Register and the Register of Population and Population
Changes.
Medical information was abstracted from antenatal records,
kept at local delivery archives and completed with data from the
Medical Birth Register. Individual record linkage between registers
and antenatal records was made possible by the Personal
Identification Number (PIN), which is assigned to each Swedish
resident and included in registers and medical records.
Sources of data
The Medical Birth Register contains prospectively collected
information on more than 99% of all births in Sweden since
1973 (Cnattingius et al, 1990). The information is provided
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filled in by midwives and physicians. The register includes data on
maternal demographics, reproductive history and complications
during pregnancy, delivery and the neonatal period. The register
contains no data on X-ray examinations.
The Cancer Register was founded in 1958 and contains
information about clinical and histological diagnosis and date
and place of living at diagnosis. It is updated annually and has
reliable information on more than 97% of all patients with cancer
(Mattsson, 1977).
The Cause of Death Register contains data on dates and causes
of death for Swedish citizens since 1961. The coverage is more than
99.5% and data are updated annually.
The antenatal records are kept in the hospital archives and
include information on X-ray and ultrasound examinations and
complement the Medical Birth Register in smoking habits,
pregnancy symptoms and diagnoses.
Study sample
A power calculation was performed in the planning phase of the
study. By including 600 cases and an equal number of controls,
and assuming a power of 80%, a two-sided 5% significance level
and an abdominal X-ray exposure frequency of 10%, we should be
able to detect an odds ratio (OR) of at least 1.7. In the Cancer
Register, we identified 601 children born between 1975 and 1984
with a diagnosis of brain tumour before the age of 15 years. For
62 of the 601 cases, the PINs were incomplete or information on
hospital of birth was missing, which made it impossible to identify
their antenatal records. Of the remaining 539 cases, we were able to
retrieve antenatal records for 512 (95%). For the 539 control
subjects, we found 524 records (97%).
Data collection and data management
Exposure data were extracted blindly with regard to case or control
status from both antenatal records and registers. All data were
assessed by one of the authors (KS) before transfer to the database.
From the antenatal records, we included information on pregnancy
complications and other current diseases and data on X-ray
exposure. From the Medical Birth Register, we retrieved informa-
tion on maternal age and reproductive history, gestational age at
birth, birth weight and mode of delivery. Information concerning
smoking habits was collected from the Medical Birth Register (data
included from 1982) and completed by data from the antenatal
records.
Radiological examinations were divided into abdominal and
non-abdominal examinations. Abdominal examinations included
pelvimetry, X-ray for foetal position and others. Risk for CBT was
evaluated for all types of brain tumours combined and according
to subtype. Each diagnosis was classified into one of the following
subtypes: low-grade astrocytoma (astrocytoma grades I–II, benign
opticusglioma), high-grade astrocytoma (astrocytoma grades
III–IV), primitive neuroectodermal tumour (PNET) defined as
category IC–D in the modified WHO classification by Rorke
et al (1985), ependymoma (Rorke IA3, IA4), germ cell tumour
(Rorke VI, VIId) or others (rare and not completely specified
tumours).
We included information on numbers of X-ray examinations
and the gestational week when they were performed. Gestational
age was divided into trimesters: the first (gestational weeks 2–14),
second (weeks 15–28), and third (weeks 29–45). Gestational age
was calculated from data on last menstrual period, which was the
standard procedure in Sweden at this time (Hogberg and Larsson,
1997). Birth weight and head circumference are presented as small,
appropriate or large for gestational length, according to the
gender-specific Swedish reference curves for birth weight and head
circumference for gestational age (Niklasson et al, 1991).
Statistical analyses
Logistic regression was performed to evaluate the association
between prenatal exposure to diagnostic X-ray and incidence of
CBT. Estimates of ORs and 95% confidence intervals (95% CIs)
were calculated. In advance, we identified potential confounding
factors that could interfere with both exposure and outcome, and
for which it was possible to obtain information either from the
registers or the antenatal records. The following confounders were
included in the adjusted analyses: maternal age at birth, parity,
multiple birth, mother’s country of birth (Nordic country (Sweden,
Norway, Denmark, Finland and Iceland) or non-Nordic country),
hypertension during pregnancy, mode of delivery, breech position,
gestational age at birth, birth weight, head circumference at birth
and level of hospital (primary, secondary or tertiary level).
The statistical analyses were conducted with the SAS 9.1
software package.
The study was approved by the Ethics Committees at Karolinska
Institutet and Uppsala University.
RESULTS
In children with CBT, 50.4% were boys and 49.6% girls. As we
matched for gender, the distribution between sexes among
controls was similar. There were no differences in maternal
smoking habits during pregnancy between cases and controls (36
vs 37% smokers, respectively). However, the information on
smoking habits was missing for 36.5% of the sample. Further
maternal and foetal characteristics are presented in Table 1.
Among children with CBT, it was more common to be the first-
born child (P¼0.01) and to be born at a primary or secondary
level hospital (P¼0.04) than for controls. There were no other
significant differences in maternal and neonatal characteristics
between cases and controls (Table 1).
Overall, 21.1% (n¼108) of the mothers to children diagnosed
with CBT were exposed to X-ray during pregnancy compared to
21.2% (n¼111) of mothers to the children randomly selected as
controls. For abdominal X-ray, the exposure frequency was 10.7%
(n¼55) for cases and 9.4% (n¼48) for controls. Beside pelvimetry
and X-ray for foetal position, abdominal X-ray included three
scintigraphy of placenta, four scintigraphy of kidney, four plain
abdominal X-rays and one colon examination. For both cases and
controls, more than 96% of the abdominal examinations were
performed in the last trimester. Non-abdominal examinations
included 107 pulmonary and one each of skeletal, sinus and dental
X-ray. Only three individuals in each group were exposed to X-ray
more than once during the pregnancy.
Table 2 presents the distribution of CBT subtypes and age at
diagnosis. Median age for diagnosis for all CBTs was 8 years. For
subtypes, ependymomas had the lowest median age at diagnosis
(4 years) and high-grade astrocytomas had the highest (9 years).
In Table 3, the ORs for prenatal X-ray are presented by tumour
subtype. Since there were no differences between cases and
controls in frequency or timing of exposure, analyses are restricted
to children to mothers exposed to prenatal X-ray, regardless of
numbers of examinations or time of exposure. Being prenatally
exposed to abdominal X-ray was not associated with an increased
overall risk of brain tumours compared with being unexposed
(adjusted OR: 1.02, 95% CI: 0.64–1.62). When stratifying
according to histological subgroups, we found that PNET had
the highest risk estimates (adjusted OR: 1.88, CI: 0.92–3.83).
Astrocytoma low and high grade had no increased ORs (adjusted
OR: 0.72, CI: 0.36–1.42 and adjusted OR: 1.06, CI: 0.39–2.86,
respectively). As there were only 44 cases with ependymoma, it was
not possible to perform multivariate analyses to adjust for possible
confounders, and only crude risk estimates are presented. For
similar reasons, germ cell tumours (n¼17) were included in all
cancers and not analysed separately.
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Prenatal X-ray exposure does not seem to increase the overall risk
of CBT. However, for the subgroup of PNET, we found an
increased OR of 1.88 (95% CI: 0.92–3.83). PNETs are found among
the youngest children and is classified as an embryonic tumour.
Medulloblastoma is the most common tumour in the PNET group,
has a peak age of occurrence of 7 years of age and is located in the
cerebellum. The other, and more rare tumours in the PNET group,
may occur in the neonatal period (in rare cases congenitally), have
a peak age at diagnosis of about 5 years of age and are mainly
supratentorial (Sarkar et al, 2005).
It has been suggested that each cell type has a ‘window of
vulnerability’ during which neoplastic transformation may occur
(VandenBerg, 2001). Consequently, gestational age at exposure to
X-rays might be of importance when evaluating risks for CBT.
Since 96% of the abdominal X-ray examinations in this study were
performed in the third trimester, it was not possible to evaluate the
impact of time of exposure. However, the human brain grows and
develops during the whole foetal period and there is currently no
evidence that foetuses should be more sensitive to carcinogenic
factors in the early gestational period.
In the present study, mean foetal absorbed radiation dose was
hard to estimate since the X-ray examinations were not
standardised and performed at several hospitals over a 10-year
period. Foetal absorbed dose for an abdominal X-ray examination
has been reported to vary between 0.1mGy for a pelvimetry with
one anterior–posterior and one lateral film (Axelsson and Ohlsen,
1979) to more than 4mGy (Osei and Faulkner, 1999; ICRP, 2000).
In dosimeter studies, radiation doses have been found to vary by a
factor of 30 or more for the same type of examination depending
on variations in radiological techniques, choice of film, etc, (Badr
et al, 1997; ICRP, 2000). It is reported that prenatal exposure to a
radiation dose of over 10mGy may increase the risk of childhood
cancer (Doll and Wakeford, 1997). Furthermore, it is suggested
that there is no ‘safe’ threshold limit but instead a linear
relationship between exposed dose and risk increase (Doll and
Wakeford, 1997; National Research Council, 2006). Risk increases
can be expressed as excess relative risk (ERR), and from previous
studies of prenatal X-ray exposure, it is estimated that the ERR
for childhood cancer for an absorbed dosage of 10mGy is
approximately 0.5 (Wakeford and Little, 2003). Although there
are uncertainties concerning such risk estimates, the low radiation
doses in the present study suggest that an ERR of more than 0.5
would not be expected.
The study had sufficient power to detect an OR of at least 1.7
for the overall risk of CBT. However, for the analyses stratified by
histological subtypes, a larger population would probably have
been needed to find statistically significant increased risks. For the
subgroup PNET, which included 105 cases, we had a power of 52%
to detect an OR of 1.9 at the 5% significance level. Since there are
approximately 10–15 new cases of PNET among Swedish children
annually, several more years had to be included to reach sufficient
power. As the Medical Birth Register was founded in 1973, 2 years
before the start of this study, this register could not have been used
to reach the warranted number of cases with PNET, which would
be needed to increase power. A study large enough to have
sufficient statistical power for the subanalyses might be performed
by pooling data from the Nordic countries all of which have
Table 2 Distribution of histological subtypes of childhood brain tumour
and age at time for diagnosis
Age (years)
N %
25th
percentile Median
75th
percentile
Astrocytoma low grade 191 37.3 4 8 12
Astrocytoma high grade 61 11.9 6 9 11
PNET 105 20.5 3 6 10
Ependymoma 44 8.6 1 4 9.5
Germ cell tumour 17 3.3 8 9 12
Others
a 94 18.4 4 7 11
Total 512 100.0 4 8 11
PNET¼primitive neuroectodermal tumour. Age is presented as median age
together with 25th and 75th percentiles.
aTwo neurofibromas/hamartomas, seven
meningiomas, one malignant meningioma, eight haemangioma, two hemangioblastoma,
one lipoma, 23 craniopharyngioma, 32 tumours not specified as malignant or benign,
one suspected malignant tumour, 17 tumours without pathohistological diagnosis.
Table 1 Maternal and infant characteristics for 512 children diagnosed
with brain tumour and 542 children serving as controls
Childhood brain tumour Controls
N % N %
Maternal age (years)
15–24 178 34.8 167 31.9
25–34 305 59.6 320 61.1
35–44 29 5.7 37 7.1
Birth order
1 245 47.9 210 40.1
42 267 52.1 314 59.9
Multiple birth
No 502 98.0 516 98.5
Yes 10 2.0 8 1.5
Mother born in a Nordic country
Yes 491 95.9 496 94.7
No 21 4.1 28 5.3
Gestational age at birth
a (weeks)
22–32 5 1.0 7 1.3
33–36 24 4.7 23 4.4
37–41 399 77.9 412 78.6
42–45 81 15.8 78 14.9
Missing 3 0.6 4 0.8
Mode of delivery
Vaginal 425 83.0 422 80.5
Vacuum extraction 28 5.5 31 5.9
Caesarean section 59 11.5 71 13.5
Breech position
No 503 98.2 513 97.9
Yes 9 1.8 11 2.1
Birth weight, SDS
b
SGA 9 1.8 12 2.3
AGA 477 93.2 493 94.1
LGA 19 3.7 14 2.7
Missing 7 1.4 5 1.0
Head circumference, SDS
b
SGA 15 2.9 13 2.5
AGA 473 92.4 487 92.9
LGA 19 3.7 13 2.5
Missing 5 1.0 11 2.1
Level of hospital
Primary level hospital 161 31.4 150 28.6
Secondary level hospital 248 48.4 234 44.7
Tertiary level hospital 103 20.1 140 26.7
Total 512 100.0 524 100.0
AGA¼appropriate for gestational age; LGA¼large for gestational age; SDS¼stan-
dard deviation score; SGA¼small for gestational age.
aCalculated by last menstrual
period.
bStandard deviation score, according to Niklasson et al (1991).
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The strengths of this study include the population-based design,
the large number of cases of CBTs, the prospective and blinded
data collection and the small number of missed cases. We were
forced to exclude 5% of the cases and 3% of the controls, as we
could not trace their antenatal records. Since the antenatal records
are filled in and filled before any of the included cases were
diagnosed with CBT, the exclusions should not have affected the
risk estimates.
In two previous case–control studies on CBT subtypes, no
increased risk after prenatal X-ray could be detected, neither for all
CBTs nor for PNET specifically (Bunin et al, 1994; Schuz et al,
2001). In these studies, retrospective interviews on exposure data
were used and the risk of recall bias could not be excluded. In both
studies, less than 5% of the study population were exposed to
prenatal X-ray, whereas we had an exposure rate of 21%. The
present study is, to our knowledge, the first study on X-ray and
CBT subtypes with prospectively collected information from
antenatal records. The antenatal records in Sweden are standar-
dised and are considered of high quality (Cnattingius et al, 1990).
Potential weaknesses are that some X-ray examinations may not
have been noted in the records. However, we assume that such
negligence was rare and we do not suspect that any possible
misclassification of exposure would be different between cases and
controls. Although we have performed multivariate analyses and
adjusted for potential confounding factors, some other conditions
that vary with both exposure and outcome could possibly have
affected the results. Maternal smoking has, in some studies, been
associated with a small increase in risk of CBT for the child
(Brooks et al, 2004). However, as smoking was not included in the
Medical Birth Register until 1982 and earlier data from the
antenatal records were incomplete, information on smoking was
missing for 37% of the study population. Therefore, it was not
possible to include smoking in the adjusted analyses. On the other
hand, for the 63% for whom we had information on maternal
smoking; the distribution between smokers and non-smokers was
similar between cases and controls. Furthermore, low birth weight
is closely correlated to maternal smoking and adjustments for
birth weight had only minor effects on the results.
Ultrasound has, during the last two decades, become the
examination of choice for determining foetal status (position,
multiple births, etc), and antenatal pelvimetry is rarely indicated.
Nevertheless, abdominal radiation still occurs, for instance in CT
scan on maternal indications. Risks with foetal diagnostic
radiation could probably be extrapolated to the early childhood
period, since the brain still develops and grows rapidly during the
first years of life.
Our most important finding might not be the clinical implica-
tion, but in relation to the theory that prenatal or neonatal
radiation might affect the various neural cell types differently.
PNET are presumed to arise from undifferentiated neural stem
cells and little is known regarding the molecular genetic events
initiating carcinogenesis (Biegel, 1997). An interesting hypothesis
would be that neural stem cells could be extra sensitive during
their differentiation and that DNA damage caused by radiation
could initiate malignant transformation, leading to the develop-
ment of embryonic CNS tumours such as PNET. If an increased
risk of PNET after radiation exposure is confirmed in future
studies, this hypothesis could be tested further in laboratory or
animal studies, as part of the complex work of mapping the
pathogenesis of childhood brain cancer.
In conclusion, we found no increased risk for CBT after prenatal
X-ray exposure when analysed as one group. When analysing
according to subgroups, the embryonic tumours defined as PNET
showed the highest risk estimates.
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